Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

4.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

3.3K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
Fetal Circulation01:14

Fetal Circulation

3.4K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular coil embolization compared to surgical ligation of the uterine artery in a non-human primate model in a model of preeclampsia.

Laboratory animal research·2026
Same author

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Birthweight in a non-human primate model of placental ischaemia.

Pregnancy hypertension·2024
Same author

Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B.

ESMO open·2024
Same author

Comparative study of the dental health of 4-year-old children in north-eastern France between 2001 and 2018.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2024
Same author

Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K

Placental growth factor and pre-eclampsia.

K Chau1,2,3, A Hennessy1,3,4, A Makris1,4,5,6

  • 1Vascular Immunology Group, Heart Research Institute, Newtown, New South Wales, Australia.

Journal of Human Hypertension
|November 9, 2017
PubMed
Summary
This summary is machine-generated.

Placental growth factor (PlGF) is vital for predicting and treating pre-eclampsia. Low PlGF indicates abnormal placentation, and supplemental PlGF shows promise as a therapeutic option for this condition.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

11.3K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

969

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

11.3K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

969

Area of Science:

  • Reproductive biology
  • Maternal-fetal medicine
  • Biochemistry

Background:

  • Placental growth factor (PlGF) plays a crucial role in feto-placental circulation and trophoblast development.
  • Low circulating PlGF levels are observed before the clinical onset of pre-eclampsia and intrauterine growth restriction.
  • The precise role of PlGF in abnormal placentation, whether causal or consequential, is under investigation.

Purpose of the Study:

  • To review the role of PlGF in normal and pathological placental development.
  • To explore the clinical applications of PlGF in pre-eclampsia prediction, diagnosis, and treatment.
  • To discuss the therapeutic potential of PlGF supplementation in pre-eclampsia.

Main Methods:

  • Literature review focusing on placental growth factor.
  • Analysis of studies on PlGF in normal and pre-eclamptic pregnancies.
  • Examination of experimental animal models and clinical trials involving PlGF.

Main Results:

  • PlGF exhibits pro-angiogenic effects essential for placental development.
  • Low PlGF is a significant early marker for pre-eclampsia and intrauterine growth restriction.
  • Experimental treatments with supplemental PlGF have shown positive outcomes in animal models of pre-eclampsia.

Conclusions:

  • PlGF is a key molecule in placental development and a promising biomarker for pre-eclampsia.
  • Targeted use of PlGF can aid in identifying high-risk pregnancies.
  • PlGF supplementation represents a potential therapeutic strategy for pre-eclampsia that warrants further research.